With over 50% of clinical trials taking place abroad, the pharmaceutical industry is now hugely globalised and thus, multi-lingual. The numerous regulations and controls governing research stages, like animal-testing and the processes behind clinical trials, differ from country to country and language obstacles may also arise in this area. In this fast-paced, ever-expanding industry, communication needs to be effective and culturally-informed, and information must be transmitted accurately.
TJC Global can offer language experts for every aspect of the pharmaceutical industry, whether at clinical trials, as part of a medical conference, or offering language assistance during mergers and business meetings between international firms. Our vast network of professional language interpreters and translators means that whatever your language requirement, we can source an expert interpreter and or translator to support you. With over 25 years of experience, TJC Global will always provide a confidential, comprehensive and reliable translation and interpreting service.
Conferences and Symposiums
Academic Papers and Reports
Rules and Regulations
Marketing Strategies and Processes
Mergers and International Collaborations
Facilities and Resources
Audits and Assessments
TJC Global provides specialist interpreting and translation services in a wide array of specialist fields. Whatever your requirement, we can find the right linguist to assist you. If your industry or project-type is not listed here, please contact us directly with your enquiry.
Our language specialists utilise their knowledge of subject-specific terminology to deliver precise, unambiguous translations whatever the context - enabling you to communicate effectively with the rest of the world. We are also able to adapt to almost any type of project.
For a quote for interpreting services or a related enquiry, please use the Quick Quote system on the right of the page.
If you would like more information about our language services, please contact us.
A team of scientists at Kyushu University in Japan is working to develop a possible COVID-19 vaccine using silkworms, the Nikkei Asian Review reported. The vaccine is scheduled to be tested on humans in 2021. The researchers, led by Professor Takahiro Kusakabe at Kyushu University in Fukuoka, are utilising the silkworms like factories. Each worm […]Read More
The ‘Suiso Frontier’ vessel was launched on 11 December 2019 from the Kawasaki Heavy Industries shipyard in Kobe, western Japan, the company said in a press release. The carrier ship has been designed to transport hydrogen produced in Australia to Japan. Measuring 116m long and 19m wide, the vessel is capable of conveying around 1,250m3 […]Read More
UK producer of soda ash, sodium bicarbonate and salt, Tata Chemicals Europe (TCE) has announced plans to build the UK’s first industrial-scale carbon capture and utilisation demonstration plant to trap carbon dioxide emissions for use in its baking soda manufacturing operations. According to the company, the project marks a world first in capturing and purifying […]Read More